Lotus Pharmaceutical Financials
| 1795 Stock | TWD 271.50 4.00 1.45% |
Lotus |
Understanding current and past Lotus Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Lotus Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Lotus Pharmaceutical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Lotus Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lotus Pharmaceutical Co. Check Lotus Pharmaceutical's Beneish M Score to see the likelihood of Lotus Pharmaceutical's management manipulating its earnings.
Lotus Pharmaceutical Stock Summary
Lotus Pharmaceutical competes with Chung Hsin, Nan Ya, Panion BF, Adimmune Corp, and Global Unichip. Lotus Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells medicines in Taiwan, Korea, the United States, and internationally. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited. LOTUS PHARMACEUTICAL operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | TW0001795003 |
| Business Address | No 277 Song |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.lotuspharm.com.tw |
| Phone | 886 2 2700 5908 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Lotus Pharmaceutical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Lotus Stock, because this is throwing your money away. Analyzing the key information contained in Lotus Pharmaceutical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Lotus Pharmaceutical Key Financial Ratios
There are many critical financial ratios that Lotus Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Lotus Pharmaceutical reports annually and quarterly.Lotus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lotus Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Lotus Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lotus Pharmaceutical competition to find correlations between indicators driving Lotus Pharmaceutical's intrinsic value. More Info.Lotus Pharmaceutical Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Lotus Pharmaceutical Co is roughly 2.23 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lotus Pharmaceutical's earnings, one of the primary drivers of an investment's value.Lotus Pharmaceutical Systematic Risk
Lotus Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lotus Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Lotus Pharmaceutical correlated with the market. If Beta is less than 0 Lotus Pharmaceutical generally moves in the opposite direction as compared to the market. If Lotus Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lotus Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lotus Pharmaceutical is generally in the same direction as the market. If Beta > 1 Lotus Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Lotus Pharmaceutical December 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lotus Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lotus Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lotus Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Lotus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lotus Pharmaceutical's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.34 | |||
| Information Ratio | 0.0044 | |||
| Maximum Drawdown | 11.58 | |||
| Value At Risk | (2.10) | |||
| Potential Upside | 3.73 |
Additional Tools for Lotus Stock Analysis
When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.